Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Alopecia Drugs
... at a CAGR of 5.5% over the analysis period 2023-2030. Topical Alopecia Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end ... Read More
-
Global Animal Sedative Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Life Sciences BPO
... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Pharmaceutical Outsourcing Services, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$281.8 Billion ... Read More
-
Pharmaceutical Membrane Filtration
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. Filters, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$11.7 Billion by the ... Read More
-
Ampoules Packaging
... at a CAGR of 6.2% over the analysis period 2023-2030. Glass Packaging, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$5.6 Billion by the end of ... Read More
-
Atopic Dermatitis Drugs
... by 2030, growing at a CAGR of 21.1% over the analysis period 2023-2030. Biologics Drug Class, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$18.7 Billion ... Read More
-
Global Digital Twin in Healthcare Market Size, Share & Trends Analysis Report, By End-user (Healthcare Providers, Medical Device Companies, Pharmaceutical Companies, and Research Organizations and Academic Institutions), By Application (Healthcare Facility, Medical Device Design and Development, Personalized Diagnosis and Treatment Planning, Drug Discovery and Development, and Others), By Region (North America, Europe, APAC, and Others), and Segment Forecasts, 2023 – 2030
... Development, Personalized Diagnosis and Treatment Planning, Drug Discovery and Development, and Others), By Region (North America, Europe, APAC, and Others), and Segment Forecasts, 2023 – 2030 Global Digital Twin in Healthcare Market Size, Share & ... Read More
-
Global Alpha Glucosidase Inhibitors Market 2024-2028
... forecast period. The report on the alpha glucosidase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Pharmaceutical Contract Packaging
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Primary Packaging, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.7 Billion by ... Read More
-
Global Pharmaceutical Lyophilization System Market Report, History and Forecast 2019-2030
... US$ 945.06 million by 2030, growing at a CAGR of 5.04% during the forecast period 2024-2030. North American market for Pharmaceutical Lyophilization System was valued at $ 178.62 million in 2023 and will reach $ ... Read More
-
Analytical Standards
... at a CAGR of 4.8% over the analysis period 2023-2030. Organic Analytical Standards, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.5 Billion by the end ... Read More
-
Pharmaceutical Wholesalers (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceutical Wholesalers (UK) report will tell you the companies that have ... Read More
-
Antiemetic Drugs
... at a CAGR of 5.4% over the analysis period 2023-2030. Chemotherapy Application, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$3.2 Billion by the end of ... Read More
-
Antifungal Drugs
... at a CAGR of 4.2% over the analysis period 2023-2030. Azoles Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$10.7 Billion by the end ... Read More
-
Diabetes Drugs
... at a CAGR of 9.3% over the analysis period 2023-2030. Insulin, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$123.1 Billion by the end of the ... Read More
-
Pharmaceutical Glass Tubing
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Glass Tubing for Syringes, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$8.1 ... Read More
-
Lifestyle Drugs
... at a CAGR of 3.0% over the analysis period 2023-2030. Obesity Drugs, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$21.4 Billion by the end of ... Read More
-
Pharmaceutical Grade Sodium Chloride
... reach US$973.7 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Dialysis End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach ... Read More
-
Pharmacy Automation
... at a CAGR of 6.9% over the analysis period 2023-2030. Medication Dispensing Systems, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.3 Billion by the end ... Read More
-
Intermediate Bulk Container
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Chemical End-Use, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$6.4 Billion by ... Read More
-
Alpha-1 Antitrypsin Drugs
... by 2030, growing at a CAGR of 9.6% over the analysis period 2023-2030. Prolastin C Drug, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$2.1 Billion ... Read More
-
Isosorbide
... of 7.4% over the analysis period 2023-2030. PEIT Application, one of the segments analyzed in the report, is expected to record a 9% CAGR and reach US$439.5 Million by the end of the analysis period. ... Read More
-
Dosing Systems
... at a CAGR of 4% over the period 2023-2030. Diaphragm Dosing Systems, one of the segments analyzed in the report, is expected to record 4.3% CAGR and reach US$5.1 Billion by the end of the ... Read More
-
Pharmaceutical Manufacturers & Distributors (UK) - Industry Report
... failure • Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceutical Manufacturers & Distributors (UK) report will ... Read More
-
Pharmaceutical and Toiletry Goods Wholesaling in New Zealand - Industry Market Research Report
... a challenging supply chain environment and weakening consumer spending power caused by high inflation. Despite these challenges, revenue is rising at an annualised 1.1% over the five years to 2022-23, to $6.4 billion, as wholesalers ... Read More
Research Assistance
